Page 899 - Clinical Immunology_ Principles and Practice ( PDFDrive )

870 Part SEVEN Organ-Specific Inflammatory Disease

involvement and may be linked to antibasement membrane IgG 53. Lawley TJ, Strober W, Yaoita H, et al. Small intestinal biopsies and HLA
production. Br J Dermatol 2001;145(3):406–14. types in dermatitis herpetiformis patients with granular and linear IgA
47. Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, et al. Rituximab for skin deposits. J Invest Dermatol 1980;74:9–12.
patients with refractory mucous membrane pemphigoid. Arch Dermatol 54. Marks J, Shuster S, Watson AJ. Small bowel changes in dermatitis
2011;147:843–9. herpetiformis. Lancet 1966;2:1280–2.
48. Maley A, Warren M, Haberman I, et al. Rituximab combined with 55. Grainge MJ, West J, Solaymani-Dodaran M, et al. The long-term risk of
conventional therapy versus conventional therapy alone for the treatment malignancy following a diagnosis of coeliac disease or dermatitis
of mucous membrane pemphigoid (MMP). J Am Acad Dermatol herpetiformis: a cohort study. Aliment Pharmacol Ther 2012;35:730–9.
2016;74:835–40. 56. Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in
49. Fortuna G, Salas-Alanis JC, Guidetti E, et al. A critical reappraisal of the patients with coeliac disease and dermatitis herpetiformis: 30-year
current data on drug-induced linear immunoglobulin A bullous population-based study. Dig Liver Dis 2006;38:374–80.
dermatosis: a real and separate nosological entity? J Am Acad Dermatol 57. Dieterich W, Laag E, Bruckner-Tuderman L, et al. Antibodies to tissue
2012;66:988–94. transglutaminase as serologic markers in patients with dermatitis
50. Zone JJ, Taylor TB, Meyer LJ. The 97 kDa linear IgA bullous disease herpetiformis. J Invest Dermatol 1999;113:133–6.
antigen is identical to a portion of the extracellular domain of the 58. Zone JJ, Schmidt LA, Taylor TB, et al. Dermatitis herpetiformis sera or
180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol goat anti-transglutaminase-3 transferred to human skin-grafted mice
1998;110:207–10. mimics dermatitis herpetiformis immunopathology. J Immunol
51. Paek SY, Steinberg SM, Katz SI. Remission in dermatitis herpetiformis: a 2011;186:4474–80.
cohort study. Arch Dermatol 2011;147:301–5. 59. Hall RP, Takeuchi F, Benbenisty K, et al. Cutaneous endothelial cell
52. West J, Fleming KM, Tata LJ, et al. Incidence and prevalence activation in normal skin of patients with dermatitis herpetiformis
of celiac disease and dermatitis herpetiformis in the UK over associated with increased serum levels of IL-8, sE-Selectin and TNF-α. J
two decades: population-based study. Am J Gastroenterol Invest Dermatol 2006;126:1331–7.
2014;109:757–68.
52a. Salmi TT, Hervonen K, Kautiainen H, et al. Prevalence and incidence of
dermatitis herpetiformis: a 40-year prospective study from Finland. Br J
Dermatol 2011;165(2):354–9.